BioAscent currently has two state-of-the-art Biacore 8k SPR systems. These are the industry standard and provide both very high-throughput and highly sensitive testing.
The expertise in the team, combined with the capabilities of these instruments, allows us to develop and transfer a wide range of assays. These assays are used for profiling high affinity target/small molecule interactions; screening low molecular weight fragment libraries, including our own; characterising therapeutic antibodies; and studying complex, multi-component interactions such as ternary complexes, which are important to profile when we are developing heterobifunctional molecules such as PROTACs.
